Jules Bernard Luys and the subthalamic nucleus
✍ Scribed by André Parent
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 132 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-3185
- DOI
- 10.1002/mds.1251
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Jules Bernard Luys, a highly energetic French investigator who made important contributions to anatomopathology, clinical neurology, and psychiatry, discovered the subthalamic nucleus in 1865. Unfortunately, Luys’ description of the nucleus that still bears his name, as well as his highly original insights on the role of this important motor structure, are rarely taken into account in the current thinking about the basal ganglia organization. Thus, we thought it of interest to review Luys’ contribution to our knowledge of the subthalamic nucleus and also briefly examine the other remarkable achievements of this singular figure of 19th century neurology. © 2001 Movement Disorder Society.
📜 SIMILAR VOLUMES
The role of the subthalamic nucleus (STN) in the origin of parkinsonian tremor is discussed. Previous studies in monkeys made parkinsonian by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) administration suggested a direct participation of the STN in the pathophysiology of tremor. We recorded t
Objective: In Parkinson disease (PD) patients, deep brain stimulation (DBS) of the subthalamic nucleus (STN) may contribute to certain impulsive behavior during high-conflict decisions. A neurocomputational model of the basal ganglia has recently been proposed that suggests this behavioral aspect ma
The techniques of targeting the subthalamic nucleus (STN) and the ventralis intermedius nucleus (Vim) are similar, only the coordinates are different. Targeting ideally consists of gathering all data about a target and positioning the electrode correctly within that target. The electrode should be p
The potential role for dopamine in the subthalamic nucleus was investigated in human postmortem tissue sections by examining; (1) immunostaining for tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis; (2) binding of [ 3 H]-SCH23390 (D1-like), [ 3 H]-YM-09151-2 (D2-like), and [